Non-invasive Monitoring Devices Market Size & Share, by Application (Chronic Disease Management, Acute Care Monitoring, Fitness & Wellness); End user; Acuity Level; Component; Product; Technology - Global Supply & Demand Analysis, Growth Forecasts, and Statistical Report 2026-2035

Non-invasive Monitoring Devices Market - Regional Analysis

North America Market Insights

North America in the non-invasive monitoring devices market is anticipated to garner the largest share of 40.4% by the end of 2035. The market’s growth in the region is highly attributed to the presence of a robust reimbursement policy, an increase in the chronic disease burden, the shift to home-based care services, and technological integration. According to an article published by the FDA Government in October 2023, the organization declared the Federal Register notice pertaining to Guidance Documents Related to Coronavirus Disease that was revised for 180 days to provide suitable guidance. Therefore, this policy is useful for the device to measure and detect the following physiological parameters and ensure patient monitoring.

FDA Policy for Non-invasive Monitoring Devices in North America (2023)

Source: FDA

The non-invasive monitoring devices market in the U.S. is growing significantly, owing to the existence of supportive administrative frameworks, chronic disease management, the role of the CMS in establishing reimbursement pathways, Medicare spending, and generous funding allocation from the National Institutes of Health (NIH). As per a data report published by the Health of Health Organization in 2025, the Medicare spending was USD 1.0 trillion and Medicaid was USD 87.1 billion as of 2023. This represents a 4.6% and 4.5% rise since 2022, making it suitable for catering to patients with chronic conditions in the country.

The non-invasive monitoring devices market in Canada is also growing due to the robust federal push for decentralized healthcare, aiming at combating geographic disparities in accessibility. In addition, the increased prevalence of rare disorders, a surge in the demand for remote monitoring solutions, and support through governmental investments are also uplifting the market in the country. As stated in the November 2023 ITA data report, the country’s medical device market has been estimated to be USD 6.8 billion as of 2022, which is projected to grow at 5.4% till 2028. Based on this surge, the overall healthcare expenditure in the country amounts to approximately CAD 331 billion or CAD 8,563 per capita, thereby positively impacting the market’s growth.

APAC Market Insights

Asia Pacific in the non-invasive monitoring devices market is predicted to emerge as the fastest-growing region during the forecast period. The market’s exposure in the region is propelled by the presence massive aging population, suitable government-based health and medical digitalization techniques, an increased patient pool, and the implementation of home-based monitoring services. According to the 2025 UNFPA article, 1 in 4 people in the region will be more than 60 years of age by the end of 2050, while the older population will triple and reach 1.3 billion people in the same year. This upsurge leads to increased chronic disorders, for which there is a huge growth opportunity for the overall market in the region.

Aging and Medical Components in the Asia Pacific Driving the Non-invasive Monitoring Devices Market (2025)

Source: NLM

The non-invasive monitoring devices market in China is gaining increased importance, owing to the existence of governmental policies, an increase in diabetes prevalence, which results in the glucose monitoring device demand, and effective alignment with the Healthy China 2030 initiative. According to an article published by NLM in July 2024, a survey-based study was conducted on 111,943 participants between 2005 to 2022, wherein there was an increase by 9.6% to 13.9% for diabetes prevalence among adults in Beijing aged 18 to 79 years. Additionally, there was also a surge in undiagnosed diabetes from 3.5% to 7.2%, thus creating an optimistic outlook for the market.

The non-invasive monitoring devices market in India is also developing due to the presence of the government’s Ayushman Bharat Digital Mission (ABDM), which is developing a unified and digitalized health ecosystem for directly bolstering the need for compatible and standard monitoring devices. Additionally, the Union Health Ministry’s generous fund allocation for the digital health strategy is also boosting the market’s growth. As stated in the October 2024 Ministry of Health and Family Welfare data report, more than 67 crore Ayushman Bharat Health Accounts have been created, and 42 crore health records have been linked. In addition, over 1.3 lakh infrastructures are ABDM-based, which include 17,000 private facilities, 4.7 lakh health and medical professionals, and 3.3 lakh health centers, thereby denoting massive development for the market in the country.

Europe Market Insights

Europe in the non-invasive monitoring devices market is expected to grow steadily by the end of the projected timeline. The market’s upliftment in the region is highly driven by a tactical push towards digitalized health integration, aging demographics, the requirement for efficient care models, and the Europe Health Data Space’s (EHDS) facilitation to promote telehealth services. As stated in the November 2024 NLM article, a survey-based study was conducted, wherein 53 countries of the region participated to evaluate telehealth services. This resulted in 9 countries, which is 26%, reporting unveiling telemedicine services, and almost 21, which is 60% of countries, stating that these services have been optimized, thus making it suitable for the market’s development.

The non-invasive monitoring devices market in Germany is gaining increased exposure, owing to its leadership, which is driven by the Digital Health Application, DiGA framework, to offer fast-track clearance as well as create a reimbursement pathway for digitalized health strategies. As per an article published by JMIR Publications Organizations in August 2024, Levidex, one of the most preliminary DiGA, provides a long-term license at a high expense, amounting to €2077.4. Additionally, there are other DiGAs that are effective for 3 months, ranging from an estimated €200 to €700, along with a median price of €535.4, thereby denoting the market’s growth.